Galderma Group AG (GDERF)
OTCMKTS · Delayed Price · Currency is USD
205.25
0.00 (0.00%)
Dec 16, 2025, 10:22 AM EST
Galderma Group AG Market Cap
Galderma Group AG has a market cap or net worth of $48.41 billion as of December 16, 2025. Its market cap has increased by 100.60% in one year.
Market Cap
48.41B
Enterprise Value
50.80B
Revenue
4.69B
Ranking
n/a
PE Ratio
128.06
Stock Price
$205.25
Market Cap Chart
Since March 22, 2024, Galderma Group AG's market cap has increased from 16.92B to 48.41B, an increase of 186.05%. That is a compound annual growth rate of 83.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 48.41B | 83.64% |
| Dec 30, 2024 | 26.36B | 55.77% |
| Mar 22, 2024 | 16.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Glass House Brands | 723.84M |
| Elite Pharmaceuticals | 534.83M |
| CytoDyn | 383.23M |
| Northwest Biotherapeutics | 376.54M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 311.74M |
| Nika Pharmaceuticals | 285.90M |